Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
People with type 2 diabetes could benefit from atorvastatin

People with type 2 diabetes could benefit from atorvastatin

Increased dementia risk after stroke

Increased dementia risk after stroke

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Authors redefine aging as any change in an organism over time

Authors redefine aging as any change in an organism over time

Zinc plays a crucial role in blindness

Zinc plays a crucial role in blindness

Public scandal - People with Alzheimer’s disease being denied essential drug treatments

Public scandal - People with Alzheimer’s disease being denied essential drug treatments

The prion appears to function as an evolutionary stepping stone

The prion appears to function as an evolutionary stepping stone

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

British team and NASA plan to take stem cells into space

British team and NASA plan to take stem cells into space

Alzheimer’s sufferers are more likely to have jobs that are less mentally challenging than people without Alzheimer’s disease

Alzheimer’s sufferers are more likely to have jobs that are less mentally challenging than people without Alzheimer’s disease

Approval of Cymbalta for treatment of major depressive disorder

Approval of Cymbalta for treatment of major depressive disorder

Nogo protein may control the progression of Alzheimer’s disease

Nogo protein may control the progression of Alzheimer’s disease

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Research collaboration to discover novel oral drugs for the treatment of viral infections

Research collaboration to discover novel oral drugs for the treatment of viral infections

75 percent of Americans support call for more stem cell research

75 percent of Americans support call for more stem cell research

New plan of action aims to reduce prescription drug costs by more than 50 percent

New plan of action aims to reduce prescription drug costs by more than 50 percent

Donepezil may have short-term benefit for mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.